Bahram Valamehr Net Worth & Insider Trades
Bahram Valamehr - Chief R&D Officer, Fate Therapeutics Inc
What is Bahram Valamehr's Net Worth?
The current estimated net worth of Fate Therapeutics Inc's Chief R&D Officer, Bahram Valamehr, is estimated to be about $16.06M . Bahram Valamehr owns about 179,834 units of Fate Therapeutics Inc common stock. In the last 3 years at Fate Therapeutics Inc, Bahram Valamehr has sold an estimated value of $14.12M worth.
What is Bahram Valamehr's Past Insider Trading?
Bahram Valamehr's largest purchase order was 25,000 units , worth over $72.5K on December 15, 2020. Bahram Valamehr's largest sale order was 25,000 units , worth over $2.44M on December 15, 2020. In total, Bahram Valamehr has made about 19 transactions over 3 years of their time at Fate Therapeutics Inc. Bahram Valamehr usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 17,158 units , worth over $518.69K on July 8, 2022.
Bahram Valamehr
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Bahram Valamehr's Salary in 2020?
As Chief R&D Officer of Fate Therapeutics Inc, Bahram Valamehr has a total base salary of $390,000 . Bahram Valamehr received compensation valued at about $2,459,097 in 2020 after becoming Chief R&D Officer. The vast majority of their compensation came in the form of stock awards of $549,750 , option awards of $1,324,347 , other earnings, plans or compensations of $195,000 , and
What is Bahram Valamehr's' Mailing Address?
- Mailing address is C/o Fate Therapeutics, Inc. 3535 General Atomics Court, Ste 200 San Diego CA 92121 CA
Fate Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. Scott Wolchko | 2020 | $570,000 | - | $1,451,340 | $3,222,577 | $356,250 | - | $5,600,167 |
| J. Scott Wolchko | 2019 | $540,000 | - | $4,137,500 | $5,732,955 | $310,500 | - | $10,720,955 |
| J. Scott Wolchko | 2018 | $516,000 | - | - | $2,756,998 | $258,000 | - | $3,530,998 |
| Edward J. Dulac III | 2020 | $142,500 | $137,917 | $1,420,800 | $3,786,529 | $75,833 | $120,000 | $5,683,579 |
| Bahram Valamehr, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Bahram Valamehr, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Bahram Valamehr, Ph.D. | 2018 | $321,865 | - | - | $2,138,235 | $117,250 | - | $2,577,350 |
| Cindy R. Tahl, J.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Cindy R. Tahl, J.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Cindy R. Tahl, J.D. | 2018 | $350,000 | - | - | $906,465 | $122,500 | - | $1,378,965 |
| Daniel D. Shoemaker, Ph.D. | 2020 | $390,000 | - | $549,750 | $1,324,347 | $195,000 | - | $2,459,097 |
| Daniel D. Shoemaker, Ph.D. | 2019 | $375,000 | - | $744,750 | $1,547,898 | $150,938 | - | $2,818,586 |
| Daniel D. Shoemaker, Ph.D. | 2018 | $365,000 | - | - | $842,338 | $127,750 | - | $1,335,088 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1434316/000119312521124699/d85377ddef14a.htm
What are Fate Therapeutics Inc's Past Insider Trades?
Fate Therapeutics Inc's most recent insider trade came on July 25, 2022 by Scott Wolchko who sold 36,246 units worth $1.19M . In the last 9 years, insiders at Fate Therapeutics Inc have sold an estimated value of $126.38M and bought an estimated value of $170.91M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Scott Wolchko, President and CEO, Cindy Tahl, General Counsel and Secretary, and Amir Nashat, Director .
FATE THERAPEUTICS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||